Modafinil/Armodafinil Pregnancy Exposure Registry: Final analysis published

Researchers have analysed data from the Teva Pharmaceutical Industries modafinil/armodafinil pregnancy exposure registry, to provide a final analysis of dataset. The registry describes a high incidence of major congenital malformation (13.1%). More details available here.